On ECHEMI
Home > Drugs > Ezetimibe Registered Holders
Ezetimibe structure

Ezetimibe structure

Ezetimibe

White SolidEzetimibe is ananti-hyperlipidemic drug used for lowering the plasma cholesterol levels. It is indicated as an adjunctive therapy to diet for the reduction of high-level total-C, LDL-C, and ApoB in patients suffering primary (heterozygous familial and non-familial) hypercholesterolemia. It is also used in combination therapy with HMG-CoA reductase inhibitors.Ezetimibe does not inhibit the cholesterol synthesis in the liver, or increase bile acid excretion.It takes effect throughactin

Find 55 Related Holders

MICRO LABS LTD
United States United States

API Registration Country

API Active
RAKS PHARMA PVT LTD
United States United States

API Registration Country

API Active
SYMED LABS LTD
United States United States

API Registration Country

API Active
SYNTHIMED LABS PRIVATE LTD
United States United States

API Registration Country

API Active
MATRIX PHARMACORP PRIVATE LTD
United States United States

API Registration Country

API Active
HETERO LABS LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
Nantong Chanyoo Pharmatech Co.,Ltd
Japan Japan

API Registration Country

API Active
MACLEODS PHARMACEUTICALS LTD
India India

API Registration Country

API Active
  • Founded in:

    1989-06-05 00:00:00
  • Country:

    India India
  • Address:

    304, ATLANTA ARCADE, MAROL CHURCH ROAD, ANDHERI (EAST) NA MUMBAI MH 400059 IN
  • Registered Funds:

    648.7 million INR
ALKEM LABORATORIES LTD
Brazil Brazil

API Registration Country

API Active
  • Country:

    Brazil Brazil
  • Address:

    ALKEM HOUSE, SENAPATI BAPAT MARG, EXTERIOR - EX
Recommended Suppliers of Ezetimibe
View 173 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.